DoMore Diagnostics

DoMore DiagnosticsNOME2023-03-21T09:58:18+00:00

DoMore Diagnostics

Transformation of cancer diagnostics with artificial intelligence

DoMore Diagnostics is a pioneer in utilizing artificial intelligence to increase the prognostic and predictive value of cancer tissue biopsies.

DoMore Diagnostics is based in Oslo, Norway and is headed by the CEO and Co-founder Torbjørn Furuseth.

DoMore Diagnostics joined NOME in 2022.

Company details

Website

Domorediagnostics.com

More companies

Adamant HealthNOME2024-07-09T12:33:39+00:00

Adamant Health
Adamant Health

Medical Devices
Alder TherapeuticsNOME2024-07-09T12:27:31+00:00

Alder Therapeutics
Alder Therapeutics

Therapeutics
CSW TherapeuticsNOME2024-07-09T12:20:00+00:00

CSW Therapeutics
CSW Therapeutics

Medical Devices
Inform LifeNOME2024-07-09T12:35:35+00:00

Inform Life
Inform Life

Other
Reccan DiagnosticsNOME2024-07-09T12:03:38+00:00

Reccan Diagnostics
Reccan Diagnostics

Diagnostics
Fuse VectorsNOME2024-07-09T11:39:06+00:00

Fuse Vectors
Fuse Vectors

Therapeutics
MetsystemNOME2024-05-30T11:11:02+00:00

Metsystem
Metsystem

Digital Health
Droplet IVNOME2024-04-15T08:52:38+00:00

Droplet IV
Droplet IV

Medical Devices

VIEW ALL PROJECTS